The Institute is founded to explore the true therapeutic benefits of stem cells. Our ultimate object Diabetes
2. Chronic Renal Failure
3. Parkinson's Disease
4.
Our focus is to maintain the highest levels of ethical standards in clinical trials conducted to study safety and efficacy of stem cells in accordance to good clinical practice guidelines (GCP). All our trials are approved by the Institutional Review Board and the Independent Ethics Committee, which is Registered with NIH, USA (website www.clinicaltrials.gov ).These trials are also registered with
09/11/2025
https://www.sciencedaily.com/releases/2025/11/251107010324.htm
Stanford makes stem cell transplants safer without chemo A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enabling nearly complete donor cell replacement. The a...
25/08/2023
21/04/2023
FDA approves allogeneic stem cell transplant therapy The first allogeneic stem cell transplant therapy to be approved based on Phase III study results has been granted by the FDA.
17/03/2023
Mesenchymal stem cells
Umbilical blood stem cell transplant puts woman in HIV remission A woman is in remission for HIV after she received HIV-resistant stem cells from umbilical cord blood to treat her leukaemia
08/03/2023
Patient With Parkinson Disease to Receive Compassionate Use of NK Cell Therapy SNK01 is primarily being assessed in combination and as a monotherapy for treating solid tumors.
27/12/2022
Better Microbes, Better Immunotherapy | Center for Cancer Research Cancer immunotherapy can help a patient’s immune system recognize and destroy tumors, but it does not work for everyone. Research increasingly supports the idea that microorganisms inside the gut play a role in whether or not someone responds to immunotherapy, so researchers are looking for ways t...
06/12/2022
MS patients could be offered stem cell transplants as a first-line treatment in new world-first trial A world-first trial is investigating if stem cell transplantation could be used in patients with aggressive multiple sclerosis (MS) as a first-line treatment.
05/04/2022
Book free consultation today and learn more about Stem Cell Therapy.
Schedule appointment @ +1(868)3482702
| Monday | 08:00 - 17:00 |
| Tuesday | 08:00 - 17:00 |
| Wednesday | 08:00 - 17:00 |
| Thursday | 08:00 - 17:00 |
| Friday | 08:00 - 17:00 |
| Saturday | 08:00 - 17:00 |
26/10/2024